292 related articles for article (PubMed ID: 9650605)
1. The linear-quadratic model and most other common radiobiological models result in similar predictions of time-dose relationships.
Brenner DJ; Hlatky LR; Hahnfeldt PJ; Huang Y; Sachs RK
Radiat Res; 1998 Jul; 150(1):83-91. PubMed ID: 9650605
[TBL] [Abstract][Full Text] [Related]
2. Universal survival curve and single fraction equivalent dose: useful tools in understanding potency of ablative radiotherapy.
Park C; Papiez L; Zhang S; Story M; Timmerman RD
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):847-52. PubMed ID: 18262098
[TBL] [Abstract][Full Text] [Related]
3. The linear-quadratic model is an appropriate methodology for determining isoeffective doses at large doses per fraction.
Brenner DJ
Semin Radiat Oncol; 2008 Oct; 18(4):234-9. PubMed ID: 18725109
[TBL] [Abstract][Full Text] [Related]
4. The linear-quadratic model is inappropriate to model high dose per fraction effects in radiosurgery.
Kirkpatrick JP; Meyer JJ; Marks LB
Semin Radiat Oncol; 2008 Oct; 18(4):240-3. PubMed ID: 18725110
[TBL] [Abstract][Full Text] [Related]
5. A LQ-based kinetic model formulation for exploring dynamics of treatment response of tumours in patients.
Scheidegger S; Lutters G; Bodis S
Z Med Phys; 2011 Sep; 21(3):164-73. PubMed ID: 21237624
[TBL] [Abstract][Full Text] [Related]
6. A generalized linear-quadratic model for radiosurgery, stereotactic body radiation therapy, and high-dose rate brachytherapy.
Wang JZ; Huang Z; Lo SS; Yuh WT; Mayr NA
Sci Transl Med; 2010 Jul; 2(39):39ra48. PubMed ID: 20610850
[TBL] [Abstract][Full Text] [Related]
7. Isotope selection for permanent prostate implants? An evaluation of 103Pd versus 125I based on radiobiological effectiveness and dosimetry.
Dicker AP; Lin CC; Leeper DB; Waterman FM
Semin Urol Oncol; 2000 May; 18(2):152-9. PubMed ID: 10875458
[TBL] [Abstract][Full Text] [Related]
8. The minimal FLASH sparing effect needed to compensate the increase of radiobiological damage due to hypofractionation for late-reacting tissues.
Böhlen TT; Germond JF; Bourhis J; Bailat C; Bochud F; Moeckli R
Med Phys; 2022 Dec; 49(12):7672-7682. PubMed ID: 35933554
[TBL] [Abstract][Full Text] [Related]
9. Radiobiological modelling of dose-gradient effects in low dose rate, high dose rate and pulsed brachytherapy.
Armpilia C; Dale RG; Sandilos P; Vlachos L
Phys Med Biol; 2006 Sep; 51(17):4399-411. PubMed ID: 16912389
[TBL] [Abstract][Full Text] [Related]
10. Calculated and simulated effects of heterogeneous dose distributions in radiotherapy using the dose volume inhomogeneity corrected biological equivalent dose formula with special reference to prostate cancer.
Lennernäs B; Albertsson P; Edgren M; Nilsson S
Oncol Rep; 2007 Nov; 18(5):1299-303. PubMed ID: 17914588
[TBL] [Abstract][Full Text] [Related]
11. Effect of patient variation on standard- and hypo-fractionated radiotherapy of prostate cancer.
Xiong W; Li J; Ma CM
Phys Med Biol; 2005 Apr; 50(7):1483-92. PubMed ID: 15798338
[TBL] [Abstract][Full Text] [Related]
12. LDR vs. HDR brachytherapy for localized prostate cancer: the view from radiobiological models.
King CR
Brachytherapy; 2002; 1(4):219-26. PubMed ID: 15062170
[TBL] [Abstract][Full Text] [Related]
13. Impact of tumor repopulation on radiotherapy planning.
Wang JZ; Li XA
Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):220-7. PubMed ID: 15629615
[TBL] [Abstract][Full Text] [Related]
14. Measurements of characteristics of time pattern in dose delivery in step-and-shoot IMRT.
Schäfer M; Münter M; Sterzing F; Häring P; Rhein B; Debus J
Strahlenther Onkol; 2005 Sep; 181(9):587-94. PubMed ID: 16170486
[TBL] [Abstract][Full Text] [Related]
15. Convex reformulation of biologically-based multi-criteria intensity-modulated radiation therapy optimization including fractionation effects.
Hoffmann AL; den Hertog D; Siem AY; Kaanders JH; Huizenga H
Phys Med Biol; 2008 Nov; 53(22):6345-62. PubMed ID: 18941280
[TBL] [Abstract][Full Text] [Related]
16. A radiobiological model for the relative biological effectiveness of high-dose-rate 252Cf brachytherapy.
Rivard MJ; Melhus CS; Zinkin HD; Stapleford LJ; Evans KE; Wazer DE; Odlozilíková A
Radiat Res; 2005 Sep; 164(3):319-23. PubMed ID: 16137205
[TBL] [Abstract][Full Text] [Related]
17. Compensation for changes in dose-rate in radical low-dose-rate brachytherapy: a radiobiological analysis of a randomised clinical trial.
Roberts SA; Hendry JH; Swindell R; Wilkinson JM; Hunter RD
Radiother Oncol; 2004 Jan; 70(1):63-74. PubMed ID: 15036854
[TBL] [Abstract][Full Text] [Related]
18. A comparative analysis of radiobiological models for cell surviving fractions at high doses.
Andisheh B; Edgren M; Belkić D; Mavroidis P; Brahme A; Lind BK
Technol Cancer Res Treat; 2013 Apr; 12(2):183-92. PubMed ID: 23098282
[TBL] [Abstract][Full Text] [Related]
19. Equivalence of the linear-quadratic and two-lesion kinetic models.
Guerrero M; Stewart RD; Wang JZ; Li XA
Phys Med Biol; 2002 Sep; 47(17):3197-209. PubMed ID: 12361218
[TBL] [Abstract][Full Text] [Related]
20. Comparison of (125)I stereotactic brachytherapy and LINAC radiosurgery modalities based on physical dose distribution and radiobiological efficacy.
Viola A; Major T; Julow J
Radiat Res; 2006 Jun; 165(6):695-702. PubMed ID: 16802870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
